Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Deal, Allison M  [Clear All Filters]
2021
Nakamura ZM, Deal AM, Park EM, Quillen LJ, Chien SA, Stanton KE, McCabe SD, Heiling HM, Wood WA, Shea TC, et al. A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation. J Psychosom Res. 2021;146:110503.
2020
Nakamura ZM, Deal AM, Rosenstein DL, Quillen LJ, Chien SA, Wood WA, Shea TC, Park EM. Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2020.
Nakamura ZM, Deal AM, Rosenstein DL, Quillen LJ, Chien SA, Wood WA, Shea TC, Park EM. Design of a Randomized Placebo Controlled Trial of High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation. Contemp Clin Trials. 2020:106076.
2016
Crowther A, Ocasio J, Fang F, Meidinger J, Wu J, Deal AM, Chang SX, Yuan H, Schmid R, Davis I, et al. Radiation sensitivity in a preclinical mouse model of medulloblastoma relies on the function of the intrinsic apoptotic pathway. Cancer Res. 2016.
2014
Wood WA, Deal AM, Bennett AV, Mitchell S, Abernethy AP, Basch E, Bailey C, Reeve BB. Comparison of Seven-Day and Repeated 24-Hour Recall of Symptoms in the First 100 Days Following Hematopoietic Cell Transplantation. J Pain Symptom Manage. 2014.
Allen JL, Tata PV, Fore MS, Wooten J, Rudra S, Deal AM, Sharf A, Hoffert T, Roehrs PA, Shea TC, et al. Increased BCR responsiveness in B cells from patients with chronic GVHD. Blood. 2014.